Literature DB >> 30255422

Treatment of Adult ADHD without Stimulants: Effectiveness in A Dually Diagnosed Correctional Population.

Leo Bastiaens1, Olivia Scott2, James Galus2.   

Abstract

Adult ADHD has received increased attention in the past two decades. There is a complex relationship between ADHD and substance use disorders, with ADHD being a risk factor for and a moderator in the treatment of addiction. ADHD is also a risk factor for the development of antisocial personality disorder. As a result, ADHD is prevalent in a correctional dually diagnosed population. This retrospective chart review reports on the effectiveness of the treatment for ADHD in a population with substance use disorders, residing in a correctional community center for treatment and reintegration purposes. Only patients with a primary diagnosis of ADHD were included and only nonstimulants were used. After an average of four visits, or approximately four months, patient showed a moderate response with a pretreatment to posttreatment effect size of 1.4. Sixty-four percent of patients responded and 35% remitted, according to the Clinical Global Index Severity Scale as the primary outcome measure. While stimulants are considered the first-line treatment for ADHD, they clearly present challenges in certain populations, especially in patients with significant antisocial and addiction histories. It does appear that non-stimulants are effective in this population. It is speculated that the response and remission rate could be improved by adding ADHD specific psychosocial interventions.

Entities:  

Keywords:  Addiction; Adult ADHD; Effectiveness; Non-stimulants

Mesh:

Substances:

Year:  2019        PMID: 30255422     DOI: 10.1007/s11126-018-9602-7

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  19 in total

Review 1.  Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

Authors:  Laurence L Greenhill; Steven Pliszka; Mina K Dulcan; William Bernet; Valerie Arnold; Joseph Beitchman; R Scott Benson; Oscar Bukstein; Joan Kinlan; Jon McClellan; David Rue; Jon A Shaw; Saundra Stock
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-02       Impact factor: 8.829

2.  Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder.

Authors:  F B Taylor; J Russo
Journal:  J Clin Psychopharmacol       Date:  2001-04       Impact factor: 3.153

Review 3.  ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.

Authors:  Scott H Kollins
Journal:  J Atten Disord       Date:  2008-01-11       Impact factor: 3.256

Review 4.  Non-stimulant treatment of attention-deficit/hyperactivity disorder.

Authors:  Steven R Pliszka
Journal:  CNS Spectr       Date:  2003-04       Impact factor: 3.790

5.  A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.

Authors:  Stephen V Faraone; Stephen J Glatt
Journal:  J Clin Psychiatry       Date:  2009-12-29       Impact factor: 4.384

Review 6.  Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies.

Authors:  Mats Fredriksen; Anne Halmøy; Stephen V Faraone; Jan Haavik
Journal:  Eur Neuropsychopharmacol       Date:  2012-08-20       Impact factor: 4.600

7.  Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.

Authors:  Timothy E Wilens; Lenard A Adler; Margaret D Weiss; David Michelson; Janet L Ramsey; Rodney J Moore; Didier Renard; Kathleen T Brady; Paula T Trzepacz; Leslie M Schuh; Lisa M Ahrbecker; Louise R Levine
Journal:  Drug Alcohol Depend       Date:  2008-04-09       Impact factor: 4.492

Review 8.  Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.

Authors:  Timothy E Wilens; Lenard A Adler; Jill Adams; Stephanie Sgambati; John Rotrosen; Robert Sawtelle; Linsey Utzinger; Steven Fusillo
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-01       Impact factor: 8.829

9.  Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

Authors:  David Michelson; Lenard Adler; Thomas Spencer; Frederick W Reimherr; Scott A West; Albert J Allen; Douglas Kelsey; Joachim Wernicke; Anthony Dietrich; Denái Milton
Journal:  Biol Psychiatry       Date:  2003-01-15       Impact factor: 13.382

Review 10.  Impact of ADHD and its treatment on substance abuse in adults.

Authors:  Timothy E Wilens
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

View more
  1 in total

Review 1.  Therapeutic Approaches for ADHD by Developmental Stage and Clinical Presentation.

Authors:  Alma Y Galvez-Contreras; Ivette Vargas-de la Cruz; Beatriz Beltran-Navarro; Rocio E Gonzalez-Castaneda; Oscar Gonzalez-Perez
Journal:  Int J Environ Res Public Health       Date:  2022-10-08       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.